MiCMA: An alternative treatment for refractory or recurrent Hodgkin's disease

Annals of Oncology

Volumn 11, Issue 7, 2000, Pages 867-871

  Ortu La Barbera, E ^a   Chiusolo, P ^a   Laurenti, L ^a   Menichella, G ^a   Di Febo, A L ^a   Piccirillo, N ^a   Sora, F ^a   Marra, R ^a   Teofili, L ^a   Leone, G ^a   Sica, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Hodgkin's disease; MiCMA; Salvage therapy; Stem cell transplantation

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CHLORMETHINE; CYTARABINE; DACARBAZINE; DOXORUBICIN; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HODGKIN DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CYTARABINE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MITOXANTRONE; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 0033816125     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008329127887     Document Type: Article

References (23)

1. Hodgkin's disease: Management of first relapse
2. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse
3. The second chance for advanced Hodgkin's disease
4. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure
5. Chemotherapy for advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
6. Autologous bone marrow transplant for patients with relapsed Hodgkin's disease
7. High-dose cyclophosphamide, carmustine and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease
8. Intensive therapy with cyclophosphamide, carmistine, etoposide, cisplatin, autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
9. Sequential peripheral blood progenitor cell transplantation after mobilization with salvage chemotherapy and G-CSF in patients with resistant lymphoma
10. ASHAP ± ABMT: An effective strategy for relapsing and refractory Hodgkin's disease (HD)
11. ASHAP: A regimen for cytoreduction of refractory or recurrent Hodgkin 's disease
12. A prognostic score for advanced Hodgkin's disease
13. Nonparametric estimation from incomplete observations
14. Design amd analysis of randomized clinical trials requiring prolonged observation of each patient II analysis and examples
15. ESHAP is an active regimen for relapsing Hodgkin's disease
16. One hundred auto-tranplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome
17. High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European group for blood and marrow transplantation
18. Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents
19. Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow tranplant registry
20. High-dose chemotherapy with or without total body irradiation followed by autologous bone merrow and/or peripheral blood stem-cell transplantation for patients wiyh relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors
21. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease. Analysis of the Stanford University results and prognostic indices
22. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian study group report